TABLE 1.
Patient Characteristics and Risk Factors (N = 132)
| Criteria | Results |
|---|---|
| Age | |
| Mean (range), y | 55 (29–90) |
| ≥ 65 y, No. (%) | 99 (75) |
| < 65 y, No. (%) | 33 (25) |
|
| |
| Sex, No. (%) | |
| Female | 21 (16) |
| Male | 111 (84) |
|
| |
| Race, No. (%) | |
| Black | 86 (65) |
| Other | 3 (2) |
| White | 43 (33) |
|
| |
| Body mass index | |
| Mean (range) | 33 (18–61) |
| ≤ 35, No. (%) | 88 (67) |
| > 35, No. (%) | 44 (33) |
|
| |
| Risk factors, No. (%) | |
| Hypertension | 78 (59) |
| Diabetes | 49 (37) |
| Chronic respiratory disease | 34 (26) |
| Renal disease | 24 (18) |
| Immunocompromised | 15 (11) |
| Malignancy | 14 (10) |
| Cardiovascular disease | 12 (9) |
| Chronic liver disease | 11 (8) |
|
| |
| Vaccination status, No. (%) | |
| Fulla | 22 (17) |
| Partialb | 11 (8) |
| Unvaccinated | 99 (75) |
a
Pfizer (n = 4), Janssen (n = 5), Moderna (n = 13).
b
Janssen (n = 1), Pfizer (n = 3), Moderna (n = 7).
Individuals in this category received the vaccine but did not have sufficient time to build immunity before a positive test result.